Antibiotice S.A. (BVB: ATB)
Romania
· Delayed Price · Currency is RON 2.490
0.00 (0.00%)
At close: Dec 19, 2024
Antibiotice Cash Flow Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 92.29 | 81.09 | 51.47 | 29.94 | 26.39 | 30.82 | Upgrade
|
| Depreciation & Amortization | 40.45 | 27.93 | 22.57 | 24.43 | 22.1 | 21.72 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | 2.75 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 3.04 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -5.98 | -1.1 | -3.14 | - | - | - | Upgrade
|
| Other Operating Activities | -2.78 | 2.81 | 17.4 | -9.93 | 45.56 | -31.92 | Upgrade
|
| Change in Accounts Receivable | -19.91 | -30.64 | 75.98 | - | - | - | Upgrade
|
| Change in Inventory | -5.28 | -19.05 | -40.84 | - | - | - | Upgrade
|
| Change in Unearned Revenue | -0.11 | 0 | 0.03 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 41.89 | 61.42 | -13.6 | - | - | - | Upgrade
|
| Operating Cash Flow | 140.57 | 122.46 | 115.66 | 44.44 | 94.05 | 20.63 | Upgrade
|
| Operating Cash Flow Growth | 188.21% | 5.88% | 160.28% | -52.75% | 356.00% | -1.14% | Upgrade
|
| Capital Expenditures | -96.34 | -83.03 | -37.58 | -29.05 | -47.99 | -69.18 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.49 | -15.01 | -7.47 | - | - | - | Upgrade
|
| Investing Cash Flow | -96.82 | -98.04 | -45.05 | -29.05 | -47.99 | -69.18 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 16.31 | 29.6 | Upgrade
|
| Long-Term Debt Repaid | - | -14.68 | -63.8 | -6.32 | - | - | Upgrade
|
| Total Debt Repaid | -6.98 | -14.68 | -63.8 | -6.32 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 19.42 | -14.68 | -63.8 | -6.32 | 16.31 | 29.6 | Upgrade
|
| Common Dividends Paid | -33.19 | -5.43 | -3.43 | -2.1 | -18.17 | -6.15 | Upgrade
|
| Other Financing Activities | -4.09 | -4.09 | -3.53 | - | -0 | - | Upgrade
|
| Financing Cash Flow | -17.86 | -24.2 | -70.76 | -8.42 | -1.86 | 23.45 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.14 | -0.14 | -0.26 | -0.1 | -1.4 | -0.54 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | 0.02 | - | - | - | Upgrade
|
| Net Cash Flow | 25.74 | 0.08 | -0.38 | 6.87 | 42.81 | -25.65 | Upgrade
|
| Free Cash Flow | 44.23 | 39.43 | 78.09 | 15.39 | 46.06 | -48.56 | Upgrade
|
| Free Cash Flow Growth | 36.04% | -49.50% | 407.53% | -66.60% | - | - | Upgrade
|
| Free Cash Flow Margin | 6.72% | 6.41% | 15.46% | 4.06% | 13.27% | -12.29% | Upgrade
|
| Free Cash Flow Per Share | 0.07 | 0.06 | 0.12 | 0.02 | 0.07 | -0.07 | Upgrade
|
| Cash Interest Paid | 4.31 | 4.09 | 3.53 | 3.54 | 5.06 | 4.54 | Upgrade
|
| Cash Income Tax Paid | 4.19 | 13.02 | 3.93 | 3.61 | 2.28 | 2.67 | Upgrade
|
| Levered Free Cash Flow | 15.39 | -3.11 | 44.45 | 21.61 | 40.65 | -49.91 | Upgrade
|
| Unlevered Free Cash Flow | 18.12 | -0.52 | 46.69 | 23.81 | 43.74 | -46.98 | Upgrade
|
| Change in Net Working Capital | -11.46 | -8.7 | -23.66 | -7.03 | -46.23 | 24.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.